US Needed Simple Pragmatic COVID-19 Trial For Repurposing Candidates, Woodcock Says
One such trial is being developed, but was needed early in the pandemic to answer many lingering questions about potential COVID-19 treatments.
You may also be interested in...
Research institutions, CROs, biopharma industry and other stakeholders are asked to comment on potential governance structure that would determine when trials are needed to address disease outbreaks and other public health emergencies.
HHS Secretary Becerra answers questions about the scope of the proposed ARPA-H agency; more to come during NIH budget hearing.
Janet Woodcock has been in the lead in the commissioner race for months without an announcement, but now serious doubts are being cast on her candidacy, including the tone of remarks at a White House press briefing.